1034097
Paramesh Banerji Life Sciences, LLC — FEI 3011020725
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- December 7, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- North Brunswick, NJ (United States)
Citations
| ID | CFR | Description |
| 1049 | 21 CFR 211.22(a) | Approve or reject components, products |
| 1136 | 21 CFR 211.25(c) | Inadequate number of personnel |
| 1361 | 21 CFR 211.100(a) | Absence of Written Procedures |
| 1448 | 21 CFR 211.111 | Establishment of time limitations |
| 1928 | 21 CFR 211.166(c)(1) | Homeopathic drugs, assessment of stability |
| 3592 | 21 CFR 211.110(c) | In-process materials characteristics testing |